Oxford Biomedica Plc (OXB.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | -4,586 | -14,559 | -11,183 | 4,026 | -5,777 |
| Other Working Capital | -2,089 | -2,292 | 141 | 1,423 | -3,140 |
| Other Operating Activity | 3,167 | 29,719 | 14,021 | -10,555 | -4,201 |
| Operating Cash Flow | $-3,508 | $12,868 | $2,979 | $-5,106 | $-13,118 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -25,772 | -10,103 | -1,969 | -6,458 | -16,716 |
| Sale Of Investment | 6,270 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | 0 | -45 | N/A | N/A | N/A |
| Other Investing Activity | 104 | 52 | 38 | 47 | 38 |
| Investing Cash Flow | $-19,398 | $-10,096 | $-1,931 | $-6,411 | $-16,678 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 38,897 | 0 | 27,812 |
| Debt Repayment | -43,589 | N/A | -30,536 | 0 | -3,000 |
| Common Stock Issued | 55,477 | 21,184 | 385 | 19,622 | 144 |
| Other Financing Activity | -4,983 | -6,041 | -10,800 | -2,125 | 0 |
| Financing Cash Flow | $6,905 | $15,143 | $-2,054 | $17,497 | $24,956 |
| Beginning Cash Position | 32,244 | 14,329 | 15,335 | 9,355 | 14,195 |
| End Cash Position | 16,243 | 32,244 | 14,329 | 15,335 | 9,355 |
| Net Cash Flow | $-16,001 | $17,915 | $-1,006 | $5,980 | $-4,840 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,508 | 12,868 | 2,979 | -5,106 | -13,118 |
| Capital Expenditure | -25,774 | -10,148 | -1,969 | -6,458 | -16,716 |
| Free Cash Flow | -29,282 | 2,720 | 1,010 | -11,564 | -29,834 |